Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment

BACKGROUND: Immune checkpoint inhibitors (ICIs) are an essential treatment for non-small cell lung cancer (NSCLC). Currently, the tumor-related intrinsic factors in response to ICIs have mostly been elucidated in tissue samples. However, tissue immune status and changes in the immune microenvironmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyunsu, Park, Sehhoon, Han, Kyoung-Yeon, Lee, Naeun, Kim, Hyemin, Jung, Hyun Ae, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Lee, Se-Hoon, Park, Woong-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930609/
https://www.ncbi.nlm.nih.gov/pubmed/36787939
http://dx.doi.org/10.1136/jitc-2022-005509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930609/
https://www.ncbi.nlm.nih.gov/pubmed/36787939
http://dx.doi.org/10.1136/jitc-2022-005509

Ejemplares similares